- Trials with a EudraCT protocol (43)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
43 result(s) found for: Cardiac Pacemaker.
Displaying page 1 of 3.
EudraCT Number: 2010-019442-87 | Sponsor Protocol Number: DROPPAF | Start Date*: 2010-07-02 |
Sponsor Name:East Sussex NHS Trust | ||
Full Title: Dronedarone in pacemaker patients with paroxysmal atrial fibrillation | ||
Medical condition: Paroxysmal atrial fibrillation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000833-38 | Sponsor Protocol Number: ISIS329993-CS6 | Start Date*: 2012-06-19 | |||||||||||
Sponsor Name:Isis Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2 Study to Assess the Antiarrhythmic and Symptomatic Effect of the Second Generation Antisense Oligonucleotide ISIS 329993 Targeting CRP in Patients with Paroxysmal Atrial Fibrillation | |||||||||||||
Medical condition: Atrial fibrillation (AF) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-006090-25 | Sponsor Protocol Number: GARBK8273 | Start Date*: 2012-03-06 | |||||||||||
Sponsor Name:Tartu Ülikooli kardioloogiakliinik | |||||||||||||
Full Title: The Impact of Heart Rate on Central Hemodynamics of Antihypertensive Therapy | |||||||||||||
Medical condition: Patients with dual chamber (atrium and ventricle) cardiac pacemaker placed due to sick sinus syndrome (at least 1 month after implantation) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022947-39 | Sponsor Protocol Number: CV203-010 | Start Date*: 2011-03-18 | ||||||||||||||||
Sponsor Name:Bristol-Myers Squibb International Corporation | ||||||||||||||||||
Full Title: Randomized, Double-Blind, Placebo-Controlled, 4-Way Crossover Study to Evaluate the Safety, Tolerability and Effect on Atrial Fibrillation Burden of BMS-914392 in Patients with Paroxysmal Atrial Fi... | ||||||||||||||||||
Medical condition: Atrial Fibrillation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-000459-10 | Sponsor Protocol Number: PADIT | Start Date*: 2014-06-10 | |||||||||||
Sponsor Name:Population Health Research Institute (PHRI) | |||||||||||||
Full Title: A cluster Crossover Trial Comparing Conventionl vs Incremental Antibiotic Therapy for the Prevention or Arrhytmia Device Infection | |||||||||||||
Medical condition: high-risk patients undergoing arrhythmia device procedures | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-001560-19 | Sponsor Protocol Number: CSCC-ASC2 | Start Date*: 2015-06-29 | |||||||||||
Sponsor Name:Department of Cardiology, Rigshospitalet | |||||||||||||
Full Title: Allogeneic adipose tissue-derived stromal/stem cell therapy in patients with ischemic heart disease and heart failure | |||||||||||||
Medical condition: Ischemic heart disease and heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-002929-19 | Sponsor Protocol Number: SCIENCE | Start Date*: 2017-01-17 | |||||||||||
Sponsor Name:Department of Cardiology, Rigshospitalet | |||||||||||||
Full Title: Stem Cell therapy in IschEmic Non-treatable Cardiac disease - SCIENCE | |||||||||||||
Medical condition: Ischemic heart disease and heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) DK (Completed) SI (Ongoing) DE (Ongoing) AT (Ongoing) PL (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-001397-33 | Sponsor Protocol Number: ARTESIA | Start Date*: 2015-09-15 | |||||||||||
Sponsor Name:Hamilton Health Sciences through the Population Health Research Institute | |||||||||||||
Full Title: APIXABAN FOR THE REDUCTION OF THROMBO-EMBOLISM IN PATIENTS WITH DEVICE-DETECTED SUB-CLINICAL ATRIAL FIBRILLATION | |||||||||||||
Medical condition: Device-detected sub-clinical atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) NL (Ongoing) GB (GB - no longer in EU/EEA) BE (Ongoing) DE (Ongoing) SE (Ongoing) ES (Ongoing) DK (Completed) HU (Ongoing) AT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-004202-25 | Sponsor Protocol Number: PI18/01297 | Start Date*: 2019-06-05 | |||||||||||
Sponsor Name:Luis Nombela Franco | |||||||||||||
Full Title: Usefulness of amiodarone for the Prevention of new onset Atrial Fibrillation after transcatheter aortic valve implantation: a randomized controlled trial | |||||||||||||
Medical condition: atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003997-33 | Sponsor Protocol Number: NOAH-AFNET6 | Start Date*: 2016-11-18 | |||||||||||
Sponsor Name:Kompetenznetz Vorhofflimmern e.V. (AFNET) [Atrial Fibrillation NETwork] | |||||||||||||
Full Title: Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes | |||||||||||||
Medical condition: Atrial fibrillation (AF) is one cause of stroke. Stroke rate is increased in patients with atrial high rate episodes (AHRE, an early stage of AF) as well, even if stroke rates are lower when compa... | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Prematurely Ended) DE (Completed) GB (GB - no longer in EU/EEA) ES (Prematurely Ended) AT (Prematurely Ended) NL (Prematurely Ended) BG (Completed) SE (Prematurely Ended) PL (Prematurely Ended) CZ (Prematurely Ended) HU (Prematurely Ended) PT (Prematurely Ended) GR (Completed) DK (Prematurely Ended) IT (Prematurely Ended) RO (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002541-11 | Sponsor Protocol Number: P170912J | Start Date*: 2019-06-06 | |||||||||||
Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | |||||||||||||
Full Title: Prevention of post-operative Atrial Fibrillation by BOTulinum toxin injections into epicardial fat pads around pulmonary veins in patients undergoing cardiac surgery | |||||||||||||
Medical condition: Adult patients with indication for conventional cardiac surgery (CABG, aortic replacement, or ascending aorta surgery) will be eligible | |||||||||||||
|
|||||||||||||
Population Age: | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003153-28 | Sponsor Protocol Number: ALN-TTRSC02-003 | Start Date*: 2019-12-23 | |||||||||||
Sponsor Name:Alnylam Pharmaceuticals, Inc. | |||||||||||||
Full Title: HELIOS-B: A Phase 3 Global, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Outcomes, Efficacy and Safety of Vutrisiran in Patients with Transthyretin Amyloidosis with C... | |||||||||||||
Medical condition: Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: LV (Ongoing) PT (Ongoing) HU (Ongoing) SI (Completed) NO (Ongoing) IE (Ongoing) LT (Ongoing) ES (Ongoing) AT (Ongoing) DK (Ongoing) DE (Ongoing) GB (GB - no longer in EU/EEA) PL (Ongoing) NL (Ongoing) HR (Ongoing) CZ (Ongoing) IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-001795-34 | Sponsor Protocol Number: CL-N-HTX-Paed-II/10/20 | Start Date*: 2023-01-30 | |||||||||||
Sponsor Name:Dr. Franz Köhler Chemie GmbH | |||||||||||||
Full Title: A prospective randomized single blind multicenter phase II study of organ perfusion with Custodiol-N compared with Custodiol in heart transplantation in children | |||||||||||||
Medical condition: Preservation of hearts prior to heart transplantation in children | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002511-26 | Sponsor Protocol Number: 08062019 | Start Date*: 2019-12-20 | |||||||||||
Sponsor Name:Rigshospitalet | |||||||||||||
Full Title: Repeated Injection Therapy of Allogeneic Stem Cells in Ischemic No-option Patients - A Multi-Centre Study (SCIENCE REPEAT) | |||||||||||||
Medical condition: Ischemic heart failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001458-24 | Sponsor Protocol Number: ALN-TTR02-011 | Start Date*: 2019-09-19 | |||||||||||
Sponsor Name:Alnylam Pharmaceuticals, Inc. | |||||||||||||
Full Title: APOLLO-B: A Phase 3, Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Efficacy and Safety of Patisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy (... | |||||||||||||
Medical condition: Transthyretin Amyloidosis with Cardiomyopathy (ATTR Amyloidosis with Cardiomyopathy) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Ongoing) DK (Ongoing) BG (Completed) PT (Ongoing) GB (GB - no longer in EU/EEA) NL (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002210-13 | Sponsor Protocol Number: STARC210421 | Start Date*: 2022-01-17 | |||||||||||
Sponsor Name:The department of cardiac, thoracic and vascular surgery - Odense University Hospital | |||||||||||||
Full Title: Post-Operative Atrial Fibrillation after Surgical Aortic Valve Replacement and the influence of HMG-CoA reductase inhibitors | |||||||||||||
Medical condition: Trial 2: Condition under investigation: Postoperative atrial fibrillation after surgical aortic valve replacement. In patients no prior usage of statins: 14 days prior surgery to 30days after - Ato... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-003595-11 | Sponsor Protocol Number: 2004-06-DP-119-RKF-25 | Start Date*: 2005-03-18 |
Sponsor Name:Canadian Cardiovascular Collaboration, Population Health Research Institute, McMaster University | ||
Full Title: PeriOperative ISchemic Evaluation study | ||
Medical condition: Perioperative cardiac events frequently complicate non-cardiac surgery resulting in significant morbidity, mortality and cost. There is no clear evidence from RCTs on how to lower perioperative ca... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Ongoing) ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-011291-29 | Sponsor Protocol Number: RACE 3 | Start Date*: 2011-08-16 | |||||||||||
Sponsor Name:Interuniversity Cardiology Institute of the Netherlands (ICIN) | |||||||||||||
Full Title: Routine versus Aggressive Upstream Rhythm Control for Prevention of Early Atrial Fibrillation in Heart Failure: RACE 3 | |||||||||||||
Medical condition: atrial fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-002835-27 | Sponsor Protocol Number: ION-682884-CS2 | Start Date*: 2020-03-04 | |||||||||||
Sponsor Name:Ionis Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3 Global, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) | |||||||||||||
Medical condition: Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) GB (GB - no longer in EU/EEA) DE (Ongoing) PT (Ongoing) AT (Ongoing) DK (Ongoing) BE (Ongoing) GR (Ongoing) CZ (Ongoing) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004060-40 | Sponsor Protocol Number: AGO15 | Start Date*: 2008-03-13 |
Sponsor Name:Studienzentrale AGO Austria | ||
Full Title: Phase II multicenter trial of the Austrian AGO of the combination of liposomal Doxorubicin (Myocet®) and Carboplatin in primary advanced or metastatic and recurrent endometrial cancer | ||
Medical condition: primary advanced or recurrent/metastatic endometrial cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.